Abstract 1729: Mutagenesis screens support potential best-in-class profile for neladalkib (NVL-655), a brain-penetrant and TRK-sparing ALK inhibitor
Authors: Anupong Tangpeerachaikul, Henry E. Pelish
Published: 2025-04-21
DOI:
10.1158/1538-7445.am2025-1729
Source:
Full article
Abstract
Abstract